Literature DB >> 11829531

Endotoxin-induced liver hypoxia: defective oxygen delivery versus oxygen consumption.

Philip E James1, Melanie Madhani, William Roebuck, Simon K Jackson, Harold M Swartz.   

Abstract

In vivo EPR was used to investigate liver oxygenation in a hemodynamic model of septic shock in mice. Oxygen-sensitive material was introduced either (i) as a slurry of fine particles which localized at the liver sinusoids (pO2 = 44.39 +/- 5.13 mmHg) or (ii) as larger particles implanted directly into liver tissue to measure average pO2 across the lobule (pO2 = 4.56 +/- 1.28 mmHg). Endotoxin caused decreases in pO2 at both sites early (5-15 min) and at late time points (6 h after endotoxin; sinusoid = 11.22 +/- 2.48 mmHg; lobule = 1.16 +/- 0.42 mmHg). The overall pO2 changes observed were similar (74.56% versus 74.72%, respectively). Blood pressures decreased transiently between 5 and 15 min (12.88 +/- 8% decrease) and severely at 6 h (59 +/- 9% decrease) following endotoxin, despite volume replacement with saline. Liver and circulatory nitric oxide was elevated at these times. Liver oxygen extraction decreased from 44% in controls to only 15% following endotoxin, despite severe liver hypoxia. Arterial oxygen saturation, blood flow (hepatic artery), and cardiac output were unaffected. Pretreatment with l-NMMA failed to improve endotoxin-induced oxygen defects at either site, whereas interleukin-13 preserved oxygenation. These site-specific measurements of pO2 provide in vivo evidence that the principal cause of liver hypoxia during hypodynamic sepsis is reduced oxygen supply to the sinusoid and can be alleviated by maintaining sinusoidal perfusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11829531     DOI: 10.1006/niox.2001.0383

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  8 in total

1.  Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents.

Authors:  G Kaur; N Tirkey; S Bharrhan; V Chanana; P Rishi; K Chopra
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

2.  Effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on endothelial dysfunction, lipid peroxidation, and hepatocyte morphology in rats with sepsis-induced liver damage.

Authors:  Eray Kara; Ahmet Var; Seda Vatansever; Serap Cilaker; Yavuz Kaya; Teoman Coşkun
Journal:  Curr Ther Res Clin Exp       Date:  2004-05

3.  Temporal changes in tissue cardiorespiratory function during faecal peritonitis.

Authors:  Alex Dyson; Alain Rudiger; Mervyn Singer
Journal:  Intensive Care Med       Date:  2011-04-30       Impact factor: 17.440

4.  Hypoxia sensitization of hepatocytes to neutrophil elastase-mediated cell death depends on MAPKs and HIF-1α.

Authors:  Erica M Sparkenbaugh; Patricia E Ganey; Robert A Roth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-01-05       Impact factor: 4.052

5.  Liver histology in ICU patients dying from sepsis: a clinico-pathological study.

Authors:  John Koskinas; Ilias P Gomatos; Dina G Tiniakos; Nikolaos Memos; Maria Boutsikou; Aspasia Garatzioti; Athanasios Archimandritis; Alexander Betrosian
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

6.  Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosis.

Authors:  Miriam Moeller; Antje Thonig; Sabine Pohl; Cristina Ripoll; Alexander Zipprich
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

7.  Application of Electron Paramagnetic Resonance (EPR) Oximetry to Monitor Oxygen in Wounds in Diabetic Models.

Authors:  Céline M Desmet; Aurore Lafosse; Sophie Vériter; Paolo E Porporato; Pierre Sonveaux; Denis Dufrane; Philippe Levêque; Bernard Gallez
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

Review 8.  Bench-to-bedside review: microvascular dysfunction in sepsis--hemodynamics, oxygen transport, and nitric oxide.

Authors:  Ryon M Bateman; Michael D Sharpe; Christopher G Ellis
Journal:  Crit Care       Date:  2003-07-28       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.